Fortress Biotech, Inc. (FBIO) Operating margin 2016–2025
Fortress Biotech, Inc. (FBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-111.0%FY2025 · since FY2016: -398.7% → -111.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -111.0% | +80.4 pp |
| FY2024 | -191.4% | -23.0 pp |
| FY2023 | -168.4% | +100.3 pp |
| FY2022 | -268.8% | +5.3 pp |
| FY2021 | -274.1% | -67.3 pp |
| FY2020 | -206.7% | +95.8 pp |
| FY2019 | -302.5% | +143.8 pp |
| FY2018 | -446.4% | +74.3 pp |
| FY2017 | -520.7% | -122.0 pp |
| FY2016 | -398.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice